Current Oncology Reports

Papers
(The median citation count of Current Oncology Reports is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Changing the Perspective on Fertility Preservation for Women with Metastatic or Advanced Stage Cancer164
Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art Review162
New Developments in VHL-Associated Neuroendocrine Neoplasms128
Cardiotoxic Effects Following CAR-T Cell Therapy: A Literature Review114
Functional Outcomes and Quality of Life in Patients with Sinonasal, Nasopharyngeal, and Anterior Skull Base Tumors86
Immunotherapy in Biliary Tract Cancers: Where Are We?78
Brain Prehabilitation for Oncologic Surgery64
Surgical Management of Melanoma: Advances and Updates59
Integrating Precision Medicine into the Contemporary Management of Gynecologic Cancers51
Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas51
NRG1 Fusions: The New Kid on the Block47
Shifting Epidemiology of Hepatocellular Carcinoma in Far Eastern and Southeast Asian Patients: Explanations and Implications45
Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances44
The Value Proposition of Observation Medicine in Managing Acute Oncologic Pain41
Treatment of Metastatic Melanoma in the Elderly41
Fatty Acid Metabolism and Cancer Immunotherapy40
Management of Upper Tract Urothelial Carcinoma40
Management of In-Transit Metastases40
Head and Neck Mucosal Melanoma: Where Are We Now?39
The Provision of Complementary, Alternative, and Integrative Medicine Information and Services: a Review of World Leading Oncology Hospital Websites38
Surgical Stress and Cancer Progression: New Findings and Future Perspectives36
“What Should I Eat?”—Addressing Questions and Challenges Related to Nutrition in the Integrative Oncology Setting35
The Microbiome in Advanced Melanoma: Where Are We Now?33
Engineered T Cells: CAR T Cell Therapy and Beyond33
The Underestimated and Overlooked Burden of Diarrhea and Constipation in Cancer Patients33
Anti-PD-1: When to Stop Treatment33
Development of Delivery Systems for Local Administration of Cytokines/Cytokine Gene-Directed Therapeutics: Modern Oncologic Implications32
Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan32
An Overview of Angiogenesis in Bladder Cancer32
Cellular Therapy in NSCLC: Between Myth and Reality31
Current Trends and Challenges of Microbiome Research in Prostate Cancer30
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients30
The Difficult Airway in Patients with Cancer30
Primary or Interval Debulking Surgery in Advanced Ovarian Cancer: a Personalized Decision—a Literature Review29
AXL Inhibitors: Status of Clinical Development29
How Have Targeted Agents Changed the Treatment Landscape for Elderly Patients with CLL?29
Appendiceal Neuroendocrine Neoplasms: an Update for 202328
Current Status of Stem Cell Transplant in Treatment of Testicular Germ Cell Tumors28
Targeting the PI3K Pathway in Gynecologic Malignancies28
Novel Surgical Initiatives in Gastroenteropancreatic Neuroendocrine Tumours28
What Is the Status of Immunotherapy in Neuroendocrine Neoplasms?27
Cancer Pain Management—New Therapies26
Proton Therapy in The Treatment of Head And Neck Cancers- Review26
CAR-T Therapies in Solid Tumors: Opportunities and Challenges25
Breast cancer Treatment and Fertility Preservation: A Narrative Review of Impacts, Strategies and Ethical Considerations25
Pitfalls and Successes in Trials in Older Transplant Patients with Hematologic Malignancies25
Current Approaches in Hepatoblastoma—New Biological Insights to Inform Therapy25
Biomarkers in the Immuno-oncology Interface of Triple Negative Breast Cancer: A Scoping Review with Perioperative Considerations24
Geographical Disparities in Colorectal Cancer in Canada: A Review24
Evolving Role of CAR T Cell Therapy in First- and Second-Line Treatment of Large B Cell Lymphoma23
Use of Circulating Tumor DNA to Guide Decision-making in Adjuvant Colon Cancer23
Surgical Management of the Primary Tumor in Stage IV Small Intestinal Neuroendocrine Tumors: To Operate or Not to Operate, That Is the Question23
Pre- and Post-Microsurgical Rehabilitation Interventions and Outcomes on Breast Cancer–Related Lymphedema: a Systematic Review23
Treatments on the Horizon: Breast Cancer Patients with Central Nervous System Metastases23
Diagnostic Accuracy of Liquid Biopsy for Oral Potentially Malignant Disorders and Head and Neck Cancer: an Overview of Systematic Reviews22
Helping Patients Understand and Cope with BRCA Mutations22
Current Management of Neuroendocrine Tumour Liver Metastases22
Antibody-Drug Conjugates in Breast Cancer: The Road Towards Biologically-Informed Selection and Sequencing22
Inequities Among Cancer Caregivers with Diverse Identities: A Review of the Literature and Future Directions22
Surgery for Recurrent Epithelial Ovarian Cancer22
Role of the Microbiome and Diet for Response to Cancer Checkpoint Immunotherapy: A Narrative Review of Clinical Trials21
Vascular Inflammation, Cancer, and Cardiovascular Diseases21
A Systematic Review and a Meta-analysis of Randomized Controlled Trials’ Control Groups in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)21
Critical Review of the Current Evidence on Sentinel Node Biopsy in Oral Cancer21
Development of Effective Siglec-9 Antibodies Against Cancer21
Evolving Treatment Approaches to Mucosal Melanoma21
Controversies in the Treatment of Adolescents and Young Adults with Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia20
Dedifferentiated Chondrosarcoma: Diagnostic Controversies and Emerging Therapeutic Targets20
Small Cell and Other Rare Histologic Types of Cervical Cancer20
Cardioprotection for Anti-HER2 Therapy: Considerations for Primary Prevention and Use in Mildly Reduced Left Ventricular Ejection Fraction20
Advancements in the Diagnosis, Treatment, and Risk Stratification of Non-Muscle Invasive Bladder Cancer19
Management of Peripheral T-cell Lymphomas and the Role of Transplant19
Is PD-1 Inhibitor Monotherapy a New Standard Treatment for MMR-Deficient Locally Advanced Rectal Cancer?19
Emerging Disparities in Prevention and Survival Outcomes for Patients with Head and Neck Cancer and Recommendations for Health Equity19
Chronic Lymphocytic Leukemia in the SARS-CoV-2 Pandemic18
The Evidence for Using Artificial Intelligence to Enhance Prostate Cancer MR Imaging18
Ependymoma: Evaluation and Management Updates18
Rehabilitation in Advanced Cancer Patients with Bone Metastases and Neural Compromise: Current Status and Future Directions18
Current Diagnostic Tools for Breast Cancer-Related Lymphedema18
Elderly Rectal Cancer: An Updated Review18
Multimodality Therapies for Localized Prostate Cancer17
Therapeutic Management in Elderly Male Breast Cancer Patients: A Scoping Review17
History of Leukemia, Revisited17
Human Epidermal Growth Factor Receptor 2 Positive Advanced Gastric or Esophagogastric Adenocarcinoma: Reflecting on the Past to Gain a New Insights17
Current Status on Management of Primary Plasma Cell Leukemia17
Integrative Medicine Across the Pediatric Cancer Care Trajectory: A Narrative Review17
Statins for Cardiac and Vascular Protection During and After Cancer Therapy17
Intratumoral Immunotherapy: Is It Ready for Prime Time?17
Treatment Approaches for Melanomas That Relapse After Adjuvant or Neoadjuvant Therapy17
Immunological Insights into Opioid-Free Anaesthesia in Oncological Surgery: A Scoping Review17
Cured or Not? Long-term Outcomes of Immunotherapy Responders. Focus on Melanoma16
Unveiling the Hidden Links: Periodontal Disease, Fusobacterium Nucleatum, and Cancers16
Return to Intended Oncological Therapy: State of the Art and Perspectives16
Richter’s Transformation16
Epidemiology of Cancer in Older Adults: A Systematic Review16
Blood–Brain Barrier Disruption for the Treatment of Primary Brain Tumors: Advances in the Past Half-Decade16
Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours16
Management of Pathologic Node-Positive Prostate Cancer following Radical Prostatectomy16
Limb Amputations in Cancer: Modern Perspectives, Outcomes, and Alternatives15
Nasal Cavity and Paranasal Sinus Cancer: Diagnosis and Treatment15
Racial Disparities in Breast Cancer: from Detection to Treatment15
Targeting The Tumor Microenvironment in Lymphomas: Emerging Biological Insights and Therapeutic Strategies15
Cardiovascular Effects of Immune Checkpoint Inhibitors: More Than Just Myocarditis15
Molecular Biomarkers in Sinonasal Cancers: New Frontiers in Diagnosis and Treatment15
Current Approaches to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer15
Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions15
Fluoropyrimidine Cardiotoxicity: Incidence, Outcomes, and Safety of Rechallenge15
Bystander effect of antibody–drug conjugates: fact or fiction?15
Nectin-4: a Tumor Cell Target and Status of Inhibitor Development15
15 Years Old ALK Gene from Birth to Adolescence; Where to in NBL14
Prevention of Ovarian Cancer: Where are We Now and Where are We Going?14
Cerebrospinal Fluid Liquid Biopsies in the Evaluation of Adult Gliomas14
CDK4/6 inhibitors: The Devil is in the Detail14
The Role and Impact of Minimal Residual Disease in NSCLC14
Is Myelodysplasia a Consequence of Normal Aging?14
All-Cause Mortality Risk Prediction in Older Adults with Cancer: Practical Approaches and Limitations14
Viral and Clinical Oncology of Head and Neck Cancers14
Cardio-Oncology in Childhood: State of the Art13
Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer13
Current Role of Functional Imaging in the Management of Lymphoma13
Oral Health in Patients with History of Head and Neck Cancer: Complexity and Benefits of a Targeted Oral Healthcare Pathway13
Integration of Liquid Biopsies in Clinical Management of Metastatic Prostate Cancer13
Clinicopathological Review of Micropapillary Urothelial Carcinoma13
Advances in Treatment of Waldenström Macroglobulinemia13
CAR T-cell Therapy for Central Nervous System Lymphoma13
Radiogenomics as an Integrated Approach to Glioblastoma Precision Medicine13
Lymphatic Interventions in the Cancer Patient13
Resectability versus Operability in Early-Stage Non-Small Cell Lung Cancer13
Correction: Enhanced Recovery in Gynecologic Oncology Surgery—State of the Science13
Fertility-Sparing and Less Radical Surgery for Cervical Cancer12
Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?12
Pelvic Floor Therapy and Initial Interventions for Pelvic Floor Dysfunction in Gynecologic Malignancies12
New Developments in Image-Guided Percutaneous Irreversible Electroporation of Solid Tumors12
Perioperative Blood Transfusions and Cancer Progression: A Narrative Review12
Options for Rescue Treatment of Patients with AL Amyloidosis Exposed to Upfront Daratumumab12
Traditional Chinese Medicine Herbs for Breast Cancer Prevention and Survival: A Narrative Review of Epidemiological Studies from Taiwan12
Lymphatic Mapping and Sentinel Node Biopsy in High-Grade Uterine Cancers12
Epidemiology of cancer in older adults: a systematic review of age-related differences in solid malignancies treatment12
Percutaneous Ablation of T1b Renal Cell Carcinoma: An Overview12
Surviving Burnout as an Oncologist12
Cold-antibody Autoimmune Hemolytic Anemia: its Association with Neoplastic Disease and Impact on Therapy12
Integrative Geriatric Oncology: A Review of Current Practices12
Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis12
Rehabilitation Needs for Patients Undergoing CAR T-Cell Therapy12
Use of Antihyperglycemic Drugs and Risk of Cancer in Patients with Diabetes12
Chronodisruption and Ambulatory Circadian Monitoring in Cancer Patients: Beyond the Body Clock12
Current Issues in Treatment of Parotid Gland Cancer and Advanced Surgical Technique of Robotic Parotidectomy12
State of Rehabilitation Research in the Head and Neck Cancer Population: Functional Impact vs. Impairment-Focused Outcomes12
Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism12
Intracranial Germinomas: Diagnosis, Pathogenesis, Clinical Presentation, and Management11
Exercise as Medicine in Cardio-Oncology: Reducing Health Disparities in Hispanic and Latina Breast Cancer Survivors11
Oral Complications and Management Strategies for Cancer Patients: Principles of Supportive Oncology in Dentistry11
Perioperative NSAIDs and Long-Term Outcomes After cancer Surgery: a Systematic Review and Meta-analysis11
Locoregional Therapy in the Management of Intrahepatic Cholangiocarcinoma: Is There Sufficient Evidence to Guide Current Clinical Practice?11
Defining The Role for Hormone Therapy in Biochemically Recurrent Prostate Cancer: What Counts as a Win for Patients?11
Correction to: Postmastectomy Functional Impairments11
An Update in Anticoagulant Therapy for Patients with Cancer-Associated Venous Thromboembolism11
Managing Pain and Discomfort in Children with Cancer11
Clinical Applications and Advancements of Positron Emission Tomography/Computed Tomography in Cardio-Oncology: A Comprehensive Literature Review and Emerging Perspectives11
BTK Inhibitors and CAR T-Cell Therapy in Treating Mantle Cell Lymphoma—Finding a Dancing Partner11
Adjuvant Therapy in Node-Positive Endometrial Cancer: A Focus on Chemotherapy11
Disparities in Lung Cancer Treatment11
Post-acute Care Needs and Benefits of Inpatient Rehabilitation Care for the Oncology Patient11
Targeting Apoptosis in Cancer10
BCR/ABL-Positive Chronic Myeloid Leukemia in Children: Current Treatment Approach10
Hairy Cell Leukemia: Where Are We in 2023?10
The Microbiome’s Influence on Head and Neck Cancers10
The Future Glioblastoma Clinical Trials Landscape: Early Phase 0, Window of Opportunity, and Adaptive Phase I–III Studies10
COVID-19 in Children with Cancer10
Enhanced Recovery in Gynecologic Oncology Surgery—State of the Science10
Prostate Cancer, Pathophysiology and Recent Developments in Management: A Narrative Review10
Molecular Subgroups of Diffuse Large B Cell Lymphoma: Biology and Implications for Clinical Practice10
Oligometastatic Esophagogastric Cancer: Does It Exist and How Do We Treat It?10
Optimizing Care: Integrative Oncology in Myeloproliferative Neoplasm10
Current Status of Perioperative Therapy in Muscle-Invasive Bladder Cancer and Future Directions10
Asparaginase: How to Better Manage Toxicities in Adults10
Beneath the Surface: The Emerging Role of Ultra-Processed Foods in Obesity-Related Cancer10
Toxicities from BRAF and MEK Inhibitors: Strategies to Maximize Therapeutic Success10
Germline Mutations and Ancestry in Prostate Cancer10
Perceptions, Knowledge, and Attitudes of General Population About Prostate Cancer-Associated Risk Factors: A Systematic Review of Qualitative Studies Focusing on Lifestyle10
Cell-free Tumor DNA: a Promising Technology for Diagnosis, Surveillance and Therapeutic Decision in Urothelial Carcinoma of the Bladder9
Advances in Radionuclide Therapies for Patients with Neuro-endocrine Tumors9
Cardiovascular Disease in Adult Cancer Survivors: a Review of Current Evidence, Strategies for Prevention and Management, and Future Directions for Cardio-oncology9
Correction to: Past, Present, and Future Therapeutic Strategies for NF‑1‑Associated Tumors9
Evolving Strategies in the Management of Microsatellite Instability-High/Mismatch Repair Deficient Esophagogastric Adenocarcinoma9
Melanoma in Pediatric and Young Adult Patients9
Integrative Oncology Approaches to Reduce Recurrence of Disease and Improve Survival9
Radiation and Melanoma: Where Are We Now?9
Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths9
Integration of Postoperative Radiation Therapy with Cyclin-Dependent Kinase (CDK) Inhibitors9
Beyond Immune Checkpoint Inhibitors: Emerging Targets in Melanoma Therapy9
25 Years of Adjuvant Therapy in Melanoma: A Perspective on Current Approvals and Insights into Future Directions9
Effect of Post-diagnosis Physical Activity on Breast Cancer Recurrence: a Systematic Review and Meta-analysis9
Novel Insights of Anti-EGFR Therapy in HNSCC: Combined with Immunotherapy or Not?9
Targeted Therapy for Melanomas Without BRAF V600 Mutation9
Next-Generation Sequencing—Optimal Sequencing of Therapies in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)9
ChatGPT in Oncology Diagnosis and Treatment: Applications, Legal and Ethical Challenges9
Current Issues in Fertility Preservation Among Pediatric and Adolescent Cancer Patients8
Lung Neuroendocrine Tumors: How Does Molecular Profiling Help?8
Update on Percutaneous Ablation for Sarcoma8
Combined BRAF-Targeted Therapy with Immunotherapy in BRAF-Mutated Advanced Melanoma Patients8
Palliative Care in Paediatric Oncology: an Update8
Early Therapeutic Interventions for Newly Diagnosed Glioblastoma: Rationale and Review of the Literature8
Sequencing Targeted and Immune Therapy in BRAF-Mutant Melanoma: Lessons Learned8
Management of Recurrent HPV-Positive Oropharyngeal Squamous Cell Carcinoma: a Contemporary Review8
Translocations and Gene Fusions in Sinonasal Malignancies8
Postoperative Delirium and Neurocognitive Disorders: Updates for Providers Caring for Cancer Patients8
Epigenetic Role of Long Non-coding RNAs in Multiple Myeloma8
Cardiac Arrhythmias in Oncological Patients—Epidemiology, Risk Factors, and Management within the Context of the New ESC 2022 Guidelines8
Recent Progress in Mind–Body Therapies in Cancer Care8
Liver Cancer Etiology: Old Issues and New Perspectives8
Immune-Related Adverse Events in Patients with Lung Cancer8
Approaches to First-Line Therapy for Metastatic Clear Cell Renal Cell Carcinoma8
Older Patients with Lung Cancer: a Summary of Seminal Contributions to Optimal Patient Care8
Radiation-Induced Cardiovascular Disease: Mechanisms, Prevention, and Treatment8
Cyclin-dependent Kinases 4/6 Inhibitors in Neuroendocrine Neoplasms: from Bench to Bedside8
The Role of Hyperthermia in the Treatment of Peritoneal Surface Malignancies8
Prostate Cancer in Transgender Women: Epidemiology, Clinical Characteristics, and Management Challenges8
Central Nervous System Involvement in Adults with Acute Leukemia: Diagnosis, Prevention, and Management8
De-escalation for Human Papillomavirus-Positive Oropharyngeal Cancer: A Look at the Prospective Evidence8
Treatment Strategy for Elderly Patients with Soft Tissue Sarcoma8
Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer8
Mixed Phenotype/Lineage Leukemia: Has Anything Changed for 2021 on Diagnosis, Classification, and Treatment?7
Non-squamous Cancers of the Larynx7
Immune Checkpoint Inhibitor Rechallenge and Resumption: a Systematic Review7
Chemotherapy-Induced Peripheral Neuropathy: Diagnosis, Agents, General Clinical Presentation, and Treatments7
The Evolving Therapeutic Landscape for Malignant Pleural Mesothelioma7
Advances in Molecular Profiling and Developing Clinical Trials of CNS Germ Cell Tumors: Present and Future Directions7
Emerging Therapeutic Targets of Neuroendocrine Prostate Cancer7
Cardiotoxicities of Non-Chemotherapeutic Metastatic Breast Cancer Treatments7
Optimal Use of Tumor-Based Molecular Assays for Localized Prostate Cancer7
Novel Clinical PET Tracers in the Pipeline for Melanoma7
Managing Metastatic Extrapulmonary Neuroendocrine Carcinoma After First-Line Treatment7
Ablation of Kidney Tumors in Patients with Substantial Kidney Impairment: Current Status7
Antibody Drug Conjugates in Urological Cancers: A Review of the Current Landscape7
Immune Checkpoint Inhibitors in Geriatric Oncology7
Percutaneous Management of Breast Cancer: a Systematic Review7
Aromatase Inhibitor Musculoskeletal Syndrome and Bone Loss: a Review of the Current Literature7
Enhanced Recovery After Surgery (ERAS) in Surgical Oncology7
Advances in Radiation Oncology in Soft Tissue Sarcoma7
Current Trends and Challenges of Microbiome Research in Bladder Cancer7
Existing Health Inequities in the Treatment of Advanced and Metastatic Cancers7
Easing the Journey—an Updated Review of Palliative Care for the Patient with High-Grade Glioma7
Lymphoblastic Lymphoma: a Concise Review7
Systemic Therapy for Non-Melanoma Skin Cancers: Latest Advances7
Perioperative Anticoagulation in Patients with Cancer6
Cardiac Effects of BRAF and MEK Inhibitors: Mechanisms and Clinical Management6
Emerging Role of Biomarkers in Testicular Germ Cell Tumors6
Minimally Invasive Procedures in the Diagnosis and Treatment of Localized Prostate Cancer: an Interventional Radiologist’s Perspective6
Cellular Therapy for Children with Central Nervous System Tumors: Mining and Mapping the Correlative Data6
0.31614279747009